Dr. Taylor has a passion for treating patients as individuals. In practice since 1994, she has a wide range of experience in treating patients with many types of movement disorders and dementias. In addition to patient care, she is actively involved in the training of residents and medical students, and has been both primary and secondary investigator in numerous research studies through the years. She is a Clinical Assistant Professor at Michigan State University's College of Osteopathic Medicine (Department of Neurology and Ophthalmology). She graduated with a BS degree from Alma College, and an MS (biomechanics) from Michigan State University. She received her medical degree from Michigan State University College of Osteopathic Medicine. Her internship and residency were completed at Botsford General Hospital. Additionally, she completed a fellowship in movement disorders with Dr. Peter LeWitt. She has been named a fellow of the American College of Neuropsychiatrists. She is board-certified in neurology by the American Osteopathic Board of Neurology and Psychiatry. She has authored several articles and lectured extensively; she continues to write questions for two national medical boards. Dr. Taylor is a member of the Medical and Scientific Advisory Council (MSAC) of the Alzheimer's Association of Michigan, and is a reviewer for the journal Clinical Neuropharmacology.
Melissa Conrad Stöppler, MD, is a U.S. board-certified Anatomic Pathologist with subspecialty training in the fields of Experimental and Molecular Pathology. Dr. Stöppler's educational background includes a BA with Highest Distinction from the University of Virginia and an MD from the University of North Carolina. She completed residency training in Anatomic Pathology at Georgetown University followed by subspecialty fellowship training in molecular diagnostics and experimental pathology.
Ongoing studies are being conducted to look at the potential benefits of
medical marijuana on MS symptoms; to include chronic pain and spasticity.
Marinol and Sativex, two FDA approved forms of medical marijuana (medical
cannabis) may be beneficial in improving spasticity or bladder frequency.
People who desire CAM therapies
generally feel that conventional treatments are not effective in controlling
their symptoms or that the side effects are not acceptable.
Most CAM therapies are not covered
It is important to discuss the use
of CAM therapies with your health-care professional, since some CAM therapies
may interact adversely with medications.
CAM has not been shown to have
significant effects on the progression of MS over time.
What is complementary or alternative treatment or CAM?
CAM (complementary and alternative medicine) is care provided in addition
(integrative medicine) to
or instead of traditional or standard medical practices. This group of therapies
is wide-ranging, and includes:
Some people who seek out alternative medicine feel that conventional therapy has
not successfully controlled their symptoms, or that the potential side effects
associated with traditional therapy aren't acceptable. Others find that adding
complementary medicine to their program allows improved control of symptoms.
When complementary medicine is added to traditional routes, it is referred to as
Recent studies through the US Centers for Disease Control and Prevention
(CDC), specifically the National Health Interview Survey, suggest that as many
as 38% of residents within the United States seek out CAM.
Many therapies that are considered within the group of complementary and
alternative medicines haven't been studied extensively or investigated in
comparison to conventional treatment options.
What is of multiple sclerosis (MS)?
Multiple sclerosis (MS) is a disease that causes demyelination of the brain
and spinal cord, or a loss of the covering around axons. When this occurs, the
axons (the parts of the nerve cells that transmit impulses to other cells) don't
work well. As more areas of the central nervous system are affected by the loss
of myelin, different symptoms develop.